NCT03528642 2026-03-17Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic AstrocytomaNational Cancer Institute (NCI)Phase 1 Active not recruiting40 enrolled